91 related articles for article (PubMed ID: 3440033)
1. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
Gangadharan B; Ritschel WA; Hussain SA
Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
[TBL] [Abstract][Full Text] [Related]
2. Theophylline controlled-release formulations: in vivo-in vitro correlations.
Yu Z; Schwartz JB; Sugita ET
Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
[TBL] [Abstract][Full Text] [Related]
3. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
Ikegami K; Tagawa K; Osawa T
J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
[TBL] [Abstract][Full Text] [Related]
5. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
6. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.
Miyazaki Y; Yakou S; Takayama K
J Pharm Pharmacol; 2008 Jun; 60(6):693-8. PubMed ID: 18498704
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutic approach in designing a controlled release tablet of sodium monofluoro phosphate. Characterization of absorption sites and evaluation of modified dosage form.
Vattikonda CS; Ritschel WA; Herbert C
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):559-66. PubMed ID: 7834164
[TBL] [Abstract][Full Text] [Related]
9. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
Brouwers J; Ingels F; Tack J; Augustijns P
J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
[TBL] [Abstract][Full Text] [Related]
12. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
[TBL] [Abstract][Full Text] [Related]
13. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
Pabst G; Weber W; Müller M; Barkworth MF
Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
[TBL] [Abstract][Full Text] [Related]
14. Influence of colon degradation of polysaccharide on the oral bioavailability of theophylline from controlled release hydrophilic matrices.
Babu GV; Himasankar K; Kumar NR; Murty KV
Boll Chim Farm; 2003 Dec; 142(10):454-60. PubMed ID: 14971315
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
17. Absolute and relative bioavailability of lithium dosage forms in the beagle dog.
Banarer M; Ritschel WA
Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
19. The in vivo performance of theophylline microcapsules.
Nixon JR; Meleka MR
J Microencapsul; 1984; 1(1):65-72. PubMed ID: 6336516
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
